Moreover, the authors underlined those patients with head and neck squamous cell carcinoma carrying the − 124 C > T TERT promoter mutation in the tumors had more than double the risk of death and disease progression compared with patients whose tumors lacked this mutation. This evidence concerns the gene TERT and head and neck squamous cell carcinoma.